ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,169,060 | +67789.7% | 43,508 | -6.8% | 0.01% | -53.8% |
Q4 2022 | $1,722 | -99.9% | 46,658 | -1.8% | 0.01% | 0.0% |
Q3 2022 | $1,488,000 | -27.7% | 47,503 | -1.6% | 0.01% | -23.5% |
Q2 2022 | $2,059,000 | -6.9% | 48,258 | -0.2% | 0.02% | +6.2% |
Q1 2022 | $2,211,000 | -5.8% | 48,333 | +5.0% | 0.02% | -5.9% |
Q4 2021 | $2,348,000 | -24.8% | 46,052 | -2.6% | 0.02% | -10.5% |
Q3 2021 | $3,122,000 | -5.8% | 47,282 | -16.7% | 0.02% | -5.0% |
Q2 2021 | $3,314,000 | -19.7% | 56,757 | -1.5% | 0.02% | -20.0% |
Q1 2021 | $4,126,000 | -16.4% | 57,640 | -4.1% | 0.02% | -19.4% |
Q4 2020 | $4,935,000 | +36.3% | 60,131 | -2.2% | 0.03% | +19.2% |
Q3 2020 | $3,622,000 | +20.3% | 61,513 | -0.7% | 0.03% | +13.0% |
Q2 2020 | $3,011,000 | +34.8% | 61,973 | +7.9% | 0.02% | +15.0% |
Q1 2020 | $2,233,000 | -6.3% | 57,424 | +0.0% | 0.02% | +11.1% |
Q4 2019 | $2,384,000 | -27.6% | 57,412 | -35.7% | 0.02% | -30.8% |
Q3 2019 | $3,291,000 | +30.2% | 89,234 | +0.7% | 0.03% | +30.0% |
Q2 2019 | $2,527,000 | – | 88,607 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |